Presence of human papillomavirus sequences in tumour-derived human oral keratinocytes expressing mutant p53

European Journal of Cancer. Part B: Oral Oncology

Volumn 31, Issue 2, 1995, Pages 136-143

  Yeudall, W A ^a   Paterson, I C ^a   Patel, V ^a   Prime, S S ^a  

^a NONE

Author keywords

chemical carcinogens; gene mutation; human papillomavirus; oral cancer; p53; tumour progression; tumour suppressor; viral oncogenesis

Indexed keywords

PROTEIN P53; VIRUS DNA;

ARTICLE; CELL LINE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH CARCINOMA; PAPILLOMA VIRUS; PRIORITY JOURNAL; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; GENE EXPRESSION; GENES, P53; HUMAN; KERATINOCYTES; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; MUTATION; PAPILLOMAVIRUS, HUMAN; SMOKING; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0029079133     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(94)00030-8     Document Type: Article

References (51)

1. The p53 tumour suppressor gene
2. Alterations in tumor development in vivo mediated by expression of wild-type or mutant p53 proteins
3. T antigen is bound to a host protein in SV40-transformed cells
4. The adenovirus E1b-55Kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54K cellular protein
5. Amplification of a gene encoding a p53-associated protein in human sarcomas
6. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
7. Papillomaviruses in human cancers
8. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines
9. Human papillomaviruses and oral neoplasia
10. Detection of human papillomavirus DNA in biopsies of human oral tissue
11. Human papillomavirus DNA in biopsies of oral tissues
12. p53 point mutation in HPV negative human cervical carcinoma cell lines
13. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
14. Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens
15. Papillomaviruses, p53 and cervical cancer
16. Papillomaviruses p53 and cervical cancer
17. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes
18. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer
19. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines
20. Increased expression of mutant forms of p53 oncogene in primary lung cancer
21. Frequent mutation of the p53 gene in human esophageal cancer
22. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis
23. Frequent p53 mutations in head and neck cancer
24. p53 mutation in human cancers
25. CRC Factsheet 14
26. Expression of p53 in premalignant and malignant squamous epithelium
27. The behaviour of human oral squamous cell carcinoma in cell culture
28. Epidermis
29. Isolation of human-p53-specific monoclonal antibodies and their use in the study of p53 expression
30. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx
31. Recent advances in the etiology and epidemiology of head and neck cancer
32. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours
33. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity
34. Mutation of the endogenous p53 gene in cells transformed by HPV-16 E7 and EJ c-ras confers a growth advantage involving an autocrine mechanism
35. “Hit and run” transformation of mouse C127 cells by bovine papillomavirus type 4: the viral DNA is required for the initiation but not for maintenance of the transformed phenotype
36. Mutation of the p53 gene in human acute myelogenous leukemia
37. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features
38. Different tumor-derived p53 mutants exhibit distinct biological activities
39. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
40. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck
41. Expression of the tumour suppressor gene p53 in oral cancer
42. Relationship of tobacco/alcohol use to p53 expression in patients with lingual squamous cell carcinomas
43. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
44. UV induced p53 mutations in squamous cell carcinoma
45. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group
46. The p53 tumor suppressor gene and ras oncogene mutations in oral squamous cell carcinoma
47. Synergism between pairs of immortalizing genes in transformation assays of rat embryo fibroblasts
48. Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination
49. Ras gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions
50. Ras mutations in United Kingdom examples of oral malignancies are rare